Acquiring Company
Hemant Surgical Industries Limited
Acquired Company
Lifesenz Cancer Research Labs Private Limited
MumbaiMumbaiBiotechnologyHealth CareMedicalMedical DeviceBiotechnologyHealth CareMedicalTherapeuticsHealth DiagnosticsDescription
Hemant Surgical Industries Limited has acquired a 66.66% stake in Lifesenz Cancer Research Labs for ₹19.99 crore. The acquisition aims to enhance their capabilities in healthcare and cancer diagnostics. Lifesenz will become a subsidiary after the deal's completion. The transaction was approved on May 27, 2026.
Who to call at Hemant Surgical Industries Limited, and when
When Hemant Surgical Industries Limited changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Hemant Surgical Industries Limited raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Hemant Surgical Industries Limited, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Hemant Surgical Industries Limited. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Hemant Surgical Industries Limited makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Lifesenz Cancer Research Labs Private Limited?
Lifesenz Cancer Research Labs Private Limited was acquired by Hemant Surgical Industries Limited, based in Mumbai. The deal was reported on May 27, 2026. Hemant Surgical Industries Limited specializes in the healthcare sector with a focus on surgical instruments. The company aims to expand its market reach through strategic acquisitions. Hemant Surgical Industries Limited is privately held and operates in Biotechnology.
When did Hemant Surgical Industries Limited acquire Lifesenz Cancer Research Labs Private Limited?
Hemant Surgical Industries Limited's acquisition of Lifesenz Cancer Research Labs Private Limited was reported on May 27, 2026. Hemant Surgical Industries Limited has acquired a 66.66% stake in Lifesenz Cancer Research Labs for ₹19.99 crore. The acquisition aims to enhance their capabilities in healthcare and cancer diagnostics. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Lifesenz Cancer Research Labs Private Limited do?
Lifesenz Cancer Research Labs provides predictive therapy solutions for clinicians and cancer patients. Established in 2022, it focuses on assisting in cancer diagnostics and research. It is privately held, operating in Biotechnology, and is based in Mumbai.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.